Apr 16, 2020
2020 Harrington Prize Awarded to Dr. Stuart H. Orkin, Boston Children's Hospital
Feb 10, 2020
Global Hemoglobin A1c Testing Market Drivers, Restraints & Opportunities Over the Forecast Period, 2019-2027 - ResearchAndMarkets.com
Jan 22, 2020
Aruvant Receives Orphan Drug Designation for ARU-1801 for the Treatment of Sickle Cell Disease
Sep 03, 2019
OrSense NBM-200 Non-Invasive Hemoglobin Device Implemented by Children's Hospital Los Angeles
Aug 27, 2019
Primary PartnerCare® Study Demonstrates Increased Frequency of Hemoglobin A1c Tests Improves Quality of Life and Decreases Cost of Care for Diabetic Patients
Aug 22, 2019
Drawbridge Health Receives FDA 510(k) Clearance for OneDraw(TM) A1C Test System
Aug 13, 2019
A Platform for Screening Drugs To Treat Sickle Cell Disease Now Offered by ReachBio Research Labs
Jun 17, 2019
Abbott Launches First-ever Rapid Point-of-Care HbA1c Test to Aid in the Diagnosis of Diabetes
May 14, 2019
FDA Grants Market Clearance for the OrSense NBM200; the First Noninvasive Hemoglobin System Cleared for Use in Blood Donation Centers
Apr 04, 2019
Biotech Support Group LLC and Pro Test Diagnostics AB Enter Supply Agreement for HemoVoid(TM) for Blood Doping Tests
Mar 07, 2019
Beckman Coulter's HbA1c Advanced Assay Provides Physicians with Greater Accuracy when Diagnosing Patients with Diabetes
Feb 20, 2019
HemoCue Announces FDA 510(k) Clearance and U.S. Launch of Its Latest Point-of-Care Hemoglobin Test, the HemoCue® Hb 801 System
Dec 03, 2018
Aruvant Sciences Presents Data from Ongoing Clinical Study of Lentiviral Gene Therapy RVT-1801 for Sickle Cell Disease at 60th Annual Meeting of the American Society of Hematology
Nov 26, 2018
Roivant Launches Aruvant Sciences and Roivant Foundation in Partnership with Cincinnati Children's Hospital Medical Center
Aug 30, 2018
Global Hemoglobin Testing Market 2018-2022 - Growing Preference for Home Care Settings / Increasing Use of POCT / Availability of Advanced Testing Devices / Rise in Elderly Population
Aug 21, 2018
Adult Hemoglobinopathy Testing Market is Projected to Grow at a CAGR of 3.9% by 2026 - Persistence Market Research
Jul 30, 2018
Sekisui Diagnostics Receives FDA Clearance for SEKURE® HbA1c Assay
Jun 11, 2018
MaxCyte and U.S. National Institutes of Health's National Heart, Lung, and Blood Institute Enter Cooperative Research & Development Agreement for Sickle Cell Disease
May 28, 2018
Global Glycated Hemoglobin Testing Market 2018-2022
May 21, 2018
MaxCyte Reports Preclinical Results at ASGCT Annual Meeting Showing Efficient Correction of Sickle Cell Mutation in Hematopoietic Stem Cells (HSC)